Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil;Preditores da adesão ao tratamento em pacientes com asma grave atendidos em um centro de referência na Bahia

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 12, 2008, Pages 995-1002

  Santos, Pablo De Moura ^a   D'Oliveira Jr , Argemiro ^a   De Araújo Costa Beisl Noblat, Lúcia ^a   Souza Machado, Adelmir ^b   Noblat, Antonio Carlos Beisl ^a   Cruz, Álvaro Augusto ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Farmacologia   (Brazil)

Author keywords

Asthma; Directly observed therapy; Patient compliance; Pharmacy; Treatment outcome

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID;

ACUTE DISEASE; ARTICLE; ASTHMA; BRAZIL; DRUG ADMINISTRATION; EPIDEMIOLOGY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; SPIROMETRY; STATISTICS;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRAZIL; DRUG ADMINISTRATION SCHEDULE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SOCIOECONOMIC FACTORS; SPIROMETRY;

EID: 59449085248     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132008001200003     Document Type: Article

References (23)

1. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization, 2007.
2. Solé D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK; ISAAC - Brazilian Group. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3. J Pediatr (Rio J). 2006;82(5):341-6.
3. Solé D, Melo KC, Camelo-Nunes IC, Freitas LS, Britto M, Rosário NA, et al. Changes in the prevalence of asthma and allergic diseases among Brazilian schoolchildren (13-14 years old): comparison between ISAAC Phases One and Three. J Trop Pediatr. 2007;53(1):13-21.
4. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J. 1996;9(4):636-42.
5. Ponte E, Souza-Machado A, Franco RA, Sarkis V, Shah K, Souza-Machado C, et al. Programa de controle da asma e da rinite alérgica na Bahia (ProAr): um modelo de integração entre assistência, ensino e pesquisa. Rev. Baiana Saúde Pública. 2004;28(1):124-132.
6. Agertoft L, Pedersen S. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol. 1997;99(6 Pt 1):773-80.
7. Saunders CE. Patient compliance in filling prescriptions after discharge from the emergency department. Am J Emerg Med. 1987;5(4):283-6.
8. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ. 1993;307(6908):846-8.
9. Spector SL, Kinsman R, Mawhinney H, Siegel SC, Rachelefsky GS, Katz RM, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol. 1986;77(1 Pt 1):65-70.
10. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-7.
11. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh G. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.
12. Sociedade Brasileira de Pneumologia e Tisiologia. III Consenso Brasileiro no Manejo da Asma. J. Pneumol. 2002;28(Supl.1):S1-S51.
13. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149(2 Pt 2):S69-76; discussion S77-8.
14. Jónasson G, Carlsen KH, Sødal A, Jonasson C, Mowinckel P. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur Respir J. 1999;14(1):150-4.
15. Chatkin JM, Cavalet-Blanco D, Scaglia NC, Tonietto RG, Wagner MB, Fritscher CC. Compliance with maintenance treatment of asthma (ADERE study). J Bras Pneumol. 2006;32(4):277-83.
16. Nagy VT, Wolfe GR. Cognitive predictors of compliance in chronic disease patients. Med Care. 1984;22(10):912-21.
17. Cluley S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med. 2001;95(1):37-9.
18. Cochrane GM. Compliance and outcomes in patients with asthma. Drugs. 1996;52 Suppl 6:12-9.
19. Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma symptoms associated with depression and lower quality of life: a population survey. Med J Aust. 2003;178(9):437-41.
20. Mancuso CA, Rincon M, McCulloch CE, Charlson ME. Self-efficacy, depressive symptoms, and patients' expectations predict outcomes in asthma. Med Care. 2001;39(12):1326-38.
21. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288-93.
22. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-310.
23. Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J. 1995;8(6):899-904.